Ascentage Pharma Group International (AAPG) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $15.37, +4.63% vs the prior close of $14.69.
- Volume 15.09K shares, 2.2x its 50-day average (heavy).
- New SEC filings: 6-K (Oct 15, 2026).
- No new insider buys or sales reported since the prior session.
AAPG jumps 4.6% to $15.37 on 2.3x normal volume. Closed at $15.37, +4.63% vs the prior close of $14.69. Day range $14.80β$15.53, opened at $14.80.
AAPG daily analysis β what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 β AAPG jumps 4.6% to $15.37 on 2.3x normal volume
- Closed at $15.37, +4.63% vs the prior close of $14.69. Day range $14.80β$15.53, opened at $14.80.
- Volume was 15.09K shares, 2.3x its 50-day average of 6.62K β unusually heavy trading.
- Price is -7.0% vs its 50-day average ($16.53) and -26.0% vs its 200-day average ($20.76).
- 52-week range $14.45β$37.50; today's close sits at 4% of that range, 59.0% below the 52-week high.
Oct 15, 2026 β AAPG dips 1.1% to $14.69, 3 down days in a row
- Closed at $14.69, -1.08% vs the prior close of $14.85. Day range $14.47β$14.93, opened at $14.69.
- Volume was 9.00K shares, 1.4x its 50-day average of 6.53K.
- Price is -11.3% vs its 50-day average ($16.56) and -29.4% vs its 200-day average ($20.81).
- 52-week range $14.45β$37.50; today's close sits at 1% of that range, 60.8% below the 52-week high.
- That makes 3 straight losses.
- SEC filings that day: 6-K.
Oct 14, 2026 β AAPG dips 1.4% to $14.85
- Closed at $14.85, -1.39% vs the prior close of $15.06. Day range $14.84β$15.06, opened at $15.06.
- Volume was 3.40K shares, 0.5x its 50-day average of 6.58K β lighter than usual.
- Price is -10.6% vs its 50-day average ($16.60) and -28.8% vs its 200-day average ($20.87).
- 52-week range $14.45β$37.50; today's close sits at 2% of that range, 60.4% below the 52-week high.
Oct 13, 2026 β AAPG dips 1.6% to $15.06
- Closed at $15.06, -1.63% vs the prior close of $15.31. Day range $14.83β$16.07, opened at $15.06.
- Volume was 10.30K shares, 1.5x its 50-day average of 6.65K.
- Price is -9.5% vs its 50-day average ($16.64) and -28.1% vs its 200-day average ($20.93).
- 52-week range $14.45β$37.50; today's close sits at 3% of that range, 59.8% below the 52-week high.
Oct 12, 2026 β AAPG jumps 3.8% to $15.31
- Closed at $15.31, +3.80% vs the prior close of $14.75. Day range $15.19β$15.45, opened at $15.19.
- Volume was 4.60K shares, 0.7x its 50-day average of 6.64K.
- Price is -8.2% vs its 50-day average ($16.67) and -27.1% vs its 200-day average ($21.00).
- 52-week range $14.45β$37.50; today's close sits at 4% of that range, 59.2% below the 52-week high.
Oct 9, 2026 β AAPG rises 1.4% to $14.75
- Closed at $14.75, +1.37% vs the prior close of $14.55. Day range $14.50β$14.80, opened at $14.50.
- Volume was 1.20K shares, 0.2x its 50-day average of 6.67K β lighter than usual.
- Price is -11.8% vs its 50-day average ($16.72) and -30.0% vs its 200-day average ($21.06).
- 52-week range $14.45β$38.58; today's close sits at 1% of that range, 61.8% below the 52-week high.
Oct 8, 2026 β AAPG dips 2.6% to $14.55, a 52-week low on 1.8x normal volume
- Closed at $14.55, -2.61% vs the prior close of $14.94. Day range $14.45β$14.89, opened at $14.89.
- Volume was 12.00K shares, 1.8x its 50-day average of 6.52K β unusually heavy trading.
- Price is -13.3% vs its 50-day average ($16.78) and -31.1% vs its 200-day average ($21.12).
- 52-week range $14.45β$40.23; today's close sits at 0% of that range, 63.8% below the 52-week high.
Oct 7, 2026 β AAPG slides 7.1% to $14.94
- Closed at $14.94, -7.15% vs the prior close of $16.09. Day range $14.85β$15.40, opened at $15.14.
- Volume was 7.20K shares, 1.1x its 50-day average of 6.47K.
- Price is -11.4% vs its 50-day average ($16.86) and -29.5% vs its 200-day average ($21.19).
- 52-week range $14.55β$40.23; today's close sits at 2% of that range, 62.9% below the 52-week high.
Oct 6, 2026 β AAPG jumps 10.2% to $16.09 on 2.3x normal volume
- Closed at $16.09, +10.17% vs the prior close of $14.60. Day range $15.22β$16.09, opened at $15.22.
- Volume was 14.50K shares, 2.3x its 50-day average of 6.22K β unusually heavy trading.
- Price is -4.9% vs its 50-day average ($16.93) and -24.3% vs its 200-day average ($21.26).
- 52-week range $14.55β$40.23; today's close sits at 6% of that range, 60.0% below the 52-week high.
Oct 5, 2026 β AAPG slides 4.9% to $14.60, a 52-week low, 3 down days in a row
- Closed at $14.60, -4.95% vs the prior close of $15.36. Day range $14.58β$14.79, opened at $14.76.
- Volume was 3.60K shares, 0.6x its 50-day average of 6.24K β lighter than usual.
- Price is -14.0% vs its 50-day average ($16.98) and -31.5% vs its 200-day average ($21.32).
- 52-week range $14.55β$40.23; today's close sits at 0% of that range, 63.7% below the 52-week high.
- That makes 3 straight losses.
Oct 2, 2026 β AAPG slides 3.4% to $15.36
- Closed at $15.36, -3.36% vs the prior close of $15.90. Day range $14.89β$15.60, opened at $15.25.
- Volume was 9.00K shares, 1.5x its 50-day average of 6.08K.
- Price is -9.9% vs its 50-day average ($17.05) and -28.2% vs its 200-day average ($21.40).
- 52-week range $14.55β$40.47; today's close sits at 3% of that range, 62.0% below the 52-week high.
AAPG latest news & SEC filings
Every SEC filing by or about AAPG in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 15, 2026 Β· Form 6-K β Report from a foreign company (6-K)
Report from a foreign company (6-K) β news it published at home
Sep 29, 2026 Β· Form 6-K β Report from a foreign company (6-K)
Report from a foreign company (6-K) β news it published at home
Sep 17, 2026 Β· Form 6-K β Report from a foreign company (6-K)
Report from a foreign company (6-K) β news it published at home
Aug 20, 2026 Β· Form 6-K β Report from a foreign company (6-K)
Report from a foreign company (6-K) β news it published at home
Aug 13, 2026 Β· Form 6-K β Report from a foreign company (6-K)
Report from a foreign company (6-K) β news it published at home
Aug 5, 2026 Β· Form 6-K β Report from a foreign company (6-K)
Report from a foreign company (6-K) β news it published at home
Aug 3, 2026 Β· Form 6-K β Report from a foreign company (6-K)
Report from a foreign company (6-K) β news it published at home
Jul 27, 2026 Β· Form 6-K β Report from a foreign company (6-K)
Report from a foreign company (6-K) β news it published at home
Jul 20, 2026 Β· Form 6-K β Report from a foreign company (6-K)
Report from a foreign company (6-K) β news it published at home
Jul 20, 2026 Β· Form F-3ASR β F-3ASR filing
F-3ASR filing
Jul 13, 2026 Β· Form 6-K β Report from a foreign company (6-K)
Report from a foreign company (6-K) β news it published at home
Jun 30, 2026 Β· Form 6-K β Report from a foreign company (6-K)
Report from a foreign company (6-K) β news it published at home
Jun 29, 2026 Β· Form 3 β New insider holdings
Initial insider ownership statement (Form 3) β a new director, officer or 10% owner disclosed their holdings
Things to know before you trade AAPG
- How much it moves: over the last 20 sessions the average daily move was 3.31% (largest 10.2%). That is a volatile stock.
- Liquidity: about 7.70K shares (β$118.42K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $15.37 vs a range of $14.45β$37.50 (4% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 6-K Oct 15, 2026; 6-K Sep 29, 2026; 6-K Sep 17, 2026.
- Listing: Nasdaq Β· industry: Pharmaceutical Preparations.
AAPG market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 14.80 | 15.53 | 14.80 | 15.37 | 15.09K |
| Oct 15, 2026 | 14.69 | 14.93 | 14.47 | 14.69 | 9.00K |
| Oct 14, 2026 | 15.06 | 15.06 | 14.84 | 14.85 | 3.40K |
| Oct 13, 2026 | 15.06 | 16.07 | 14.83 | 15.06 | 10.30K |
| Oct 12, 2026 | 15.19 | 15.45 | 15.19 | 15.31 | 4.60K |
| Oct 9, 2026 | 14.50 | 14.80 | 14.50 | 14.75 | 1.20K |
| Oct 8, 2026 | 14.89 | 14.89 | 14.45 | 14.55 | 12.00K |
| Oct 7, 2026 | 15.14 | 15.40 | 14.85 | 14.94 | 7.20K |
| Oct 6, 2026 | 15.22 | 16.09 | 15.22 | 16.09 | 14.50K |
| Oct 5, 2026 | 14.76 | 14.79 | 14.58 | 14.60 | 3.60K |
| Oct 2, 2026 | 15.25 | 15.60 | 14.89 | 15.36 | 9.00K |
| Oct 1, 2026 | 15.79 | 16.02 | 15.65 | 15.90 | 4.30K |
| Sep 30, 2026 | 15.59 | 16.50 | 15.59 | 16.31 | 13.70K |
| Sep 29, 2026 | 15.30 | 16.04 | 15.30 | 15.35 | 3.40K |
| Sep 28, 2026 | 15.00 | 15.01 | 14.55 | 14.89 | 4.80K |
| Sep 25, 2026 | 14.81 | 15.03 | 14.81 | 14.86 | 2.90K |
| Sep 24, 2026 | 15.01 | 15.23 | 14.85 | 15.23 | 15.40K |
| Sep 23, 2026 | 15.71 | 15.71 | 15.58 | 15.58 | 1.50K |
| Sep 22, 2026 | 16.02 | 16.18 | 15.87 | 15.87 | 800 |
| Sep 21, 2026 | 15.91 | 16.17 | 15.82 | 15.86 | 17.40K |
About Ascentage Pharma Group International
Ascentage Pharma Group International (AAPG) is listed on the Nasdaq and classified by the SEC under βPharmaceutical Preparationsβ. Its business address is in SUZHOU , JIANGSU. State of incorporation: Cayman Islands. Fiscal year ends December 31. SEC CIK 2023311.
AAPG board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Marina Bozilenko | Director | Mar 23, 2026 |
| Marc E Lippman | Director | Mar 23, 2026 |
| Simon Dazhong Lu | Director | Mar 23, 2026 |
| David Sidransky | Director | Mar 23, 2026 |
| Shaomeng Wang | Director | Mar 23, 2026 |
| Ren Wei | Director | Mar 23, 2026 |
| Dajun Yang | Chairman and CEO | May 22, 2026 |
| Changqing Ye | Director | Mar 23, 2026 |
| Debra Yu | Director | Mar 23, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Jin Cao | Chief Accounting Officer | Apr 20, 2026 |
| Thomas J Knapp | SVP/General Counsel | Mar 23, 2026 |
| Veet Misra | Chief Financial Officer | Apr 21, 2026 |
| Faical Miyara | Chief Business Officer | Jun 29, 2026 |
| Dajun Yang | Chairman and CEO | May 22, 2026 |
| Yifan Zhai | Chief Medical Officer | May 22, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
AAPG financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| No annual XBRL figures available (foreign filers often report on Form 20-F). | ||||
Latest balance sheet: total assets $β, total liabilities $β, cash $β.
AAPG earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks Β· Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on AAPG
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.